A set of new aryloxy-quinones were synthesized and evaluated in vitro against the epimastigote form of Trypanosoma cruzi and their unspecific cytotoxicity was tested on murine macrophages J-774 cells.Most of these novel compounds were found to be extremely more potent and selective than the standard drug nifurtimox. Interestingly, 2-phenoxy-naphthoquinone 3b displayed a remarkable nanomolar inhibitory activity, IC 50 = 20 nM, and a high selectivity index, SI = 625. The E pc1 was determined for the most interesting compounds and no correlation with the trypanosomicidal effect was found. Therefore, an in silico study was carried out to obtain a pharmacophoric model and quantitative structure-trypanosomicidal activity relationship. The designed pharmacophore recognized the more potent and selective molecules, exhibiting five pharmacophoric features. A correlation coefficient R 2 of 0.99 of pIC 50 plotted against the predicted values indicated that the 3D-QSAR equation could be applied to further predictions of newly designed trypanosomicidal compounds. 5 5a,b with nitric acid. 23 The reaction of 6a and 6b with the phenols 2a-c or naphthols 2d,e furnished regiospecifically the corresponding 7-aryloxy-quinoline-5,8-dione derivatives 7a-i (24-92% yield).Scheme 2. Synthesis of compounds of series II (7a-i). Reagents and conditions: (i) Br 2 , MeOH, rt, 5 min; (ii) HNO 3 , H 2 SO 4 , 0 °C, 30 min; 23 (iii) K 2 CO 3 , 2a-e, DMF, rt, 3-5 h.Scheme 3. Synthesis of compounds of series III (11a-i). Reagents and conditions: (i) Br 2 , CHCl 3 , rt, 1.5 h; (ii) CrO 3 , H 2 O/AcOH, rt, 2 h; (iii) K 2 CO 3 , DMF, 2a-e, rt, 2 h.